Alnylam Pharmaceuticals, Inc. (ALNY)

328.59 -0.76 (-0.23%) USD  |  NASDAQ  |  Feb 24, 14:01
More

Alnylam Pharmaceuticals EPS Basic from Tax Loss Carryforward (Quarterly)

EPS Basic from Tax Loss Carryforward (Quarterly) Chart

View EPS Basic from Tax Loss Carryforward (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Basic from Tax Loss Carryforward (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

View EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks

View EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks
Start Trial
Insmed, Inc. --
Biogen, Inc. --
Pfizer Inc. --
Eli Lilly & Co. --
AbbVie, Inc. --